Valiant Captivia
Device Aortic Stent Grafts
PDI 00643169347083
General payments
$1,781,708
Research payments
$2,370,426
Through program year 2025, $1,781,708 in general payments and $2,370,426 in research payments were reported against Valiant Captivia (Aortic Stent Grafts).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $489,226 | 1,662 |
| 2025 | Research | $157,032 | 11 |
| 2024 | General | $262,603 | 1,084 |
| 2024 | Research | $687,901 | 211 |
| 2023 | General | $439,721 | 1,815 |
| 2023 | Research | $741,732 | 180 |
| 2022 | General | $440,920 | 2,058 |
| 2022 | Research | $451,885 | 83 |
| 2021 | General | $149,237 | 715 |
| 2021 | Research | $331,876 | 29 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 41 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 40 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
7,334 general · 514 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.